Last reviewed · How we verify

LOPRAZOLAM — Competitive Intelligence Brief

LOPRAZOLAM (LOPRAZOLAM) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: loprazolam. Area: Neuroscience.

marketed loprazolam GABA-A receptor alpha-1/beta-3/gamma-2 Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

LOPRAZOLAM (LOPRAZOLAM).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
LOPRAZOLAM TARGET LOPRAZOLAM marketed loprazolam GABA-A receptor alpha-1/beta-3/gamma-2
Campral ACAMPROSATE Allergan/AbbVie marketed acamprosate GABA-A receptor alpha-1/beta-3/gamma-2 2004-01-01
Noctan METHYPRYLON Roche marketed methyprylon GABA-A receptor alpha-1/beta-3/gamma-2 1982-01-01
Ativan lorazepam Generic (originally Wyeth/Pfizer) marketed Benzodiazepine [EPC] GABA-A receptor alpha-1/beta-3/gamma-2, Fatty acid-binding protein, liver 1977-09-30
Butalbital, Aspirin And Caffeine BUTALBITAL Actavis Labs Ut Inc marketed Barbiturate [EPC] GABA-A receptor alpha-1/beta-3/gamma-2 1976-01-01
Glimid GLUTETHIMIDE Sandoz marketed GABA-A receptor alpha-1/beta-3/gamma-2 1976-01-01
Alvinol ETHCHLORVYNOL AbbVie marketed ethchlorvynol GABA-A receptor alpha-1/beta-3/gamma-2 1961-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (loprazolam class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). LOPRAZOLAM — Competitive Intelligence Brief. https://druglandscape.com/ci/loprazolam. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: